During the cognitively normal stage of AD, ApoE-ε4 noncarriers of female display significantly higher Aβ levels compared with males, whereas ApoE-ε4 carriers among males exhibit considerably greater Aβ burden than noncarriers (Pan et al., 2023). The gene discussed is APOE; the disease is Alzheimer disease.